Ligand Pharmaceuticals, Inc. (LGND)
317.74
-1.04
(-0.33%)
USD |
NASDAQ |
Oct 29, 11:49
Ligand Pharmaceuticals Market Cap : 6.329B for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 28, 2026 | 6.350B |
| October 27, 2026 | 6.210B |
| October 26, 2026 | 6.141B |
| October 23, 2026 | 6.046B |
| October 22, 2026 | 6.132B |
| October 21, 2026 | 6.270B |
| October 20, 2026 | 6.103B |
| October 19, 2026 | 5.922B |
| October 16, 2026 | 5.887B |
| October 15, 2026 | 5.946B |
| October 14, 2026 | 5.876B |
| October 13, 2026 | 6.046B |
| October 12, 2026 | 6.198B |
| October 09, 2026 | 6.012B |
| October 08, 2026 | 5.876B |
| October 07, 2026 | 5.842B |
| October 06, 2026 | 5.915B |
| October 05, 2026 | 6.111B |
| October 02, 2026 | 6.035B |
| October 01, 2026 | 6.031B |
| September 30, 2026 | 6.222B |
| September 29, 2026 | 6.182B |
| September 28, 2026 | 6.257B |
| September 25, 2026 | 6.006B |
| September 24, 2026 | 5.957B |
| Date | Value |
|---|---|
| September 23, 2026 | 5.944B |
| September 22, 2026 | 5.946B |
| September 21, 2026 | 5.778B |
| September 18, 2026 | 5.647B |
| September 17, 2026 | 5.671B |
| September 16, 2026 | 5.482B |
| September 15, 2026 | 5.517B |
| September 14, 2026 | 5.591B |
| September 11, 2026 | 5.667B |
| September 10, 2026 | 5.762B |
| September 09, 2026 | 5.738B |
| September 08, 2026 | 5.753B |
| September 04, 2026 | 5.689B |
| September 03, 2026 | 5.772B |
| September 02, 2026 | 5.715B |
| September 01, 2026 | 5.663B |
| August 31, 2026 | 5.659B |
| August 28, 2026 | 5.587B |
| August 27, 2026 | 5.668B |
| August 26, 2026 | 5.734B |
| August 25, 2026 | 5.612B |
| August 24, 2026 | 5.581B |
| August 21, 2026 | 5.703B |
| August 20, 2026 | 5.725B |
| August 19, 2026 | 5.791B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 662.27B |
| Eli Lilly & Co. | 1.287T |
| Merck & Co., Inc. | 363.61B |
| ANI Pharmaceuticals, Inc. | 1.681B |
| Corcept Therapeutics, Inc. | 9.406B |
Market Cap Related Metrics
| PE Ratio | 33.97 |
| PS Ratio | 22.83 |
| Price to Book Value | 6.542 |
| Price to Free Cash Flow | 55.34 |
| Price | 317.74 |
| Earnings Yield | 2.94% |
| Operating PE Ratio | 66.25 |
| Normalized PE Ratio | 45.15 |